European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- Instant

Monograph 0478 does not prescribe which excipients to use but sets limits on their quality and function. It explicitly warns against excipients that could impair bioavailability or cause toxicity. For example, it restricts the use of certain azo dyes (e.g., tartrazine) due to hypersensitivity risks. Furthermore, it mandates that tablets for pediatric or geriatric use must consider swallowability, often requiring a break-line (score line) with validated uniformity of subdivided parts.

is a general dosage form monograph that establishes the mandatory quality standards for tablets intended for oral administration in the European Union. It covers a wide range of tablet types, including uncoated, coated, effervescent, gastro-resistant, and orodispersible tablets. www.edqm.eu Core Definitions & Scope Definition European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more ICH Q4B Annex 5 - Disintegration Test General Chapter - EMA Monograph 0478 does not prescribe which excipients to

Tablets are defined as solid dosage forms that are prepared by compressing a mixture of active pharmaceutical ingredients and excipients. The tablets must be uniform in size, shape, and weight, and must meet specific requirements for hardness, friability, and disintegration. Furthermore, it mandates that tablets for pediatric or

: Formulated to control the rate or location (e.g., the intestine) of drug release. Mandatory Quality Controls